Capitolis Advisors’s Medtronic MDT Stock Holding History

Capitolis Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-210,868	Closed	-$21.8M	–	346
2021 Q4	$21.8M	Buy	210,868 +16,993	+9%	+$1.97M	0.13%	139
2021 Q3	$23.4M	Sell	193,875 -14,549	-7%	-$1.88M	0.21%	93
2021 Q2	$25.9M	Buy	208,424 +67,089	+47%	+$8.42M	0.3%	82
2021 Q1	$16.7M	Hold	141,335	–	–	0.29%	87
2020 Q4	$16.6M	Buy	+141,335	New	+$15.6M	0.28%	91

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capitolis Advisors's MDT Position: Q1 2022 in Review

Capitolis Advisors sold out of Medtronic (MDT) in Q1 2022, closing a stake of 210,868 shares — an estimated $21.8M sold.

Capitolis Advisors first reported a position in MDT in Q4 2020 and held it in 5 quarters. The position peaked at $25.9M in Q2 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

Capitolis Advisors reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
Capitolis Advisors sold 210,868 Medtronic shares in Q1 2022, an estimated $21.8M.
Capitolis Advisors first reported a position in Medtronic in Q4 2020 and held it in 5 quarters.
Capitolis Advisors's Medtronic position peaked at $25.9M in Q2 2021.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.